Menopausal hormone therapy: oncological risks
The article presents generalized data on cancer risks during menopausal hormone therapy (MHT). It is shown that, in proper MHT prescription, it is possible to achieve targeted treatment outcomes without increasing cancer risk.
Saved in:
| Main Authors: | I. V. Madyanov, T. S. Madyanova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Open Systems Publication
2021-06-01
|
| Series: | Лечащий Врач |
| Subjects: | |
| Online Access: | https://journal.lvrach.ru/jour/article/view/642 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Menopausal hormone therapy in certain diseases of therapeutic profile
by: I. V. Madyanov, et al.
Published: (2021-06-01) -
Alternative (non-hormonal) methods of menopausal disorder treatment. Assistance to the doctor-internist
by: I. V. Madyanov, et al.
Published: (2021-06-01) -
CPD: HoraHormone Therapy: a practical guide to risk assessment for short-term symptomatic treatment of menopausal symptomsone Therapy: a practical guide to risk assessment for short-term symptomatic treatment of menopausal symptoms.
by: E.J.C. Hugo, et al.
Published: (2004-12-01) -
Specifics of prescribing menopausal hormonal therapy in patients with the anamnestic endometriosis
by: M. I. Yarmolinskaya, et al.
Published: (2021-01-01) -
Menopausal hormone therapy in systemic lupus erythematosus: Pro et contra
by: T. S. Panevin, et al.
Published: (2023-03-01)